Increasing use of more potent treatments for psoriasis

Journal of the American Academy of Dermatology

Volumn 60, Issue 3, 2009, Pages 478-481

  Strowd, Lindsay C ^a   Yentzer, Brad A ^a   Fleischer Jr , Alan B ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

biologic agents; calcipotriene; corticosteroids; methotrexate; NAMCS; psoriasis; treatment

Indexed keywords

ADALIMUMAB; AMMONIUM LACTATE; BETAMETHASONE; CALCIPOTRIOL; CLOBETASOL; CYCLOSPORIN; DIFLORASONE; EFALIZUMAB; ERYTHROMYCIN; ETANERCEPT; ETRETIN; FLUOCINONIDE; HYDROCORTISONE; INFLIXIMAB; KETOCONAZOLE; METHOTREXATE; MOMETASONE FUROATE; SALICYLIC ACID; STEROID; TAZAROTENE; TRIAMCINOLONE; ULOBETASOL PROPIONATE; XIPAMIDE;

ADULT; BIOLOGICAL THERAPY; CONTROLLED STUDY; DRUG POTENCY; DRUG UTILIZATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; REVIEW; STEROID THERAPY;

ADRENAL CORTEX HORMONES; ADULT; BIOLOGICAL PRODUCTS; CALCITRIOL; DERMATOLOGIC AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PHYSICIAN'S PRACTICE PATTERNS; PSORIASIS;

EID: 60149106169     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.10.055     Document Type: Review

References (14)

1. Menter A., Gottlieb A., Feldman S.R., Van Voorhees A.S., Leonardi C.L., Gordon K.B., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis, section 1: overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58 (2008) 826-850
2. Stern R.S., Nijsten T., Feldman S.R., Margolis D.J., and Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9 (2004) 136-139
3. Menter A., and Griffiths C.E. Current and future management of psoriasis. Lancet 370 (2007) 272-284
4. Centers for Disease Control and Prevention. Survey instrument: National ambulatory medical care survey. Available from: URL: http://www.cdc.gov/nchs/about/major/ahcd/surinst.htm#Survey%20Instrument%20NAMCS. Accessed October 12, 2007.
5. Binns H.J., Lanier D., Pace W.D., Galliher J.M., Ganiats T.G., Grey M., et al. Describing primary care encounters: the primary care network survey and the national ambulatory medical care survey. Ann Fam Med 5 (2007) 39-47
6. Franks P., Clancy C.M., and Nutting P.A. Defining primary care: empirical analysis of the national ambulatory medical care survey. Med Care 35 (1997) 655-668
7. Balkrishnan R., Fleischer Jr. A.B., Paruthi S., and Feldman S.R. Physicians underutilize topical retinoids in the management of acne vulgaris: analysis of US national practice data. J Dermatolog Treat 14 (2003) 172-176
8. Thevarajah S., Balkrishnan R., Camacho F.T., Feldman S.R., and Fleischer Jr. A.B. Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment. J Dermatolog Treat 16 (2005) 224-228
9. Katugampola R.P., Hongbo Y., and Finlay A.Y. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life. Br J Dermatol 152 (2005) 1256-1262
10. Jarratt M.T., Clark S.D., Savin R.C., Swinyer L.J., Safley C.F., Brodell R.T., et al. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. Cutis 78 (2006) 348-354
11. Kimball A.B., Gold M.H., Zib B., and Davis M.W. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 59 (2008) 448-454
12. Housman T.S., Mellen B.G., Rapp S.R., Fleischer Jr. A.B., and Feldman S.R. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 70 (2002) 327-332
13. Leonardi C.L., Powers J.L., Matheson R.T., Goffe B.S., Zitnik R., Wang A., et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349 (2003) 2014-2022
14. Gottlieb A.B., Evans R., Li S., Dooley L.T., Guzzo C.A., Baker D., et al. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 51 (2004) 534-542